维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="GAZI IF"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Increased plasma visfatin levels in sujects with the metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
2	Gender - related and age - related urinalysis of healthy subjects by NMR - based metabonomies 显示文摘	Psihogios NC Gazi IF Elisaf MS	2008	NMR Biomed2008，21，3：	1
3	Gender - related and age - related urinalysis of healthy subjects by NMR - based metabonomics 显示文摘	Psihogios NG Gazi IF Elisaf MS	2008	NMR Biomed2008，21，3：	1
4	Non-low-density lipoprotein cholesterol associated ac-tions of ezetimibe:an overview显示文摘	Gazi IF Mikhailidis DP	2006	Expert Opin Ther Targets2006，10，：	1
5	Increased plasma visfatin levels in subjects with the metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
6	Gender-related and age-related urinalysis of healthy subjects by NMR- based metabonomics显示文摘	Psihogios NG Gazi IF Elisaf MS	2008	NMR Biomed2008，21，3：	1
7	Gender-related and age-related urinalysis of healthy subjects by NMR-basedmetabonomics显示文摘	Psihogios NG Gazi IF Elisaf MS	2008	NMR Biomed2008，21，3：	1
8	Orlistat- associated adverse effects and drug interactions: a critical review 显示文摘	FILIPPATOS TD DERDEMEZIS CS GAZI IF	2008	DrugSaf2008，31，1：	1
9	The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemia显示文摘	Ganotakis ES Gazi IF Papadakis JA	2007	Clin Appl Thromb Hemost2007，13，1：	1
10	Fibrinogen,lipoprotein(a),albumin and bilirubin(F-L-A-B)levels and cardiovascular risk calculated using the Framingham equation显示文摘	Ganotakis ES Vrentzos GE Gazi IF	2007	In Vivo2007，21，：	1
11	Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin显示文摘	Gazi IF Daskalopoulou SS Nair DR	2007	Curr Med Res Opin2007，23，9：	1
12	Orlistatassociated adverse effects and drug interactions显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Drug Saf2008，31，1：	1
13	Concentration and relative distribution of low-densitylipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria 显示文摘	Gazi IF Tsimihodimos V Eilippatos T	2006	Metabolism2006，55，7：	1
14	Increased plasma vis- fatin levels in subjects with the metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
15	Increased plasma visfatin levels in subjects with the metabolic syndrome显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
16	Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics 显示文摘	Psihogios NG Gazi IF Elisaf MS	2008	NMR Biomed2008，21，3：	1
17	Increased plasma visfatin levels in subjects with the metabolic syndrome显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，：	1
18	Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation显示文摘	Ganotakis ES Vrentzos GE Gazi IF	2007	In Vivo2007，21，4：	1
19	Increased plasma visfatin levels in subjects with the metabolic syndrome显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，4：	1
20	Acute infection with Ep-stein-Barr virus is associated with atherogenic lipid changes 显示文摘	Apostolou F Gazi IF Lagos K	2010	Atherosclerosis2010，212，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示